Australian Rheumatology Association Database

我们计划收集澳大利亚关节炎患者的健康信息，以监测新疗法的益处和安全性。所有接受新的可注射生物制剂治疗的患者和其他服用常规药物的患者将被邀请参加后续计划。我们将衡量关节炎对生活质量和身体功能的影响，以及所有关节炎药物的长期效果。这将对澳大利亚社区具有巨大的价值，因为这些数据通常不能从任何其他来源获得。它将帮助风湿科医生和患者做出有关长期关节炎治疗的最佳决定。

We plan to collect health information from Australian patients with arthritis to monitor the benefits and safety of new treatments. All patients being treated with the new injectable biologic agents and other patients taking conventional drugs will be invited to take part in the follow up program. We will measure the impact of arthritis on quality of life and physical function and the long-term effects of all arthritis drugs. This will be of immense value to the Australian community as this data are not routinely available from any other source. It will help rheumatologists and patients make the best decisions regarding long-term arthritis treatments.